[noon announcement: Haiscox innovative drug HSK34890 tablet new drug application accepted] Financial Associated Press, June 2, a number of companies issued lunch announcements, as follows: ① Guangji Pharmaceutical Co., Ltd.: the company invested 10 million yuan to set up a wholly-owned subsidiary Hubei Guangji Health Technology Co., Ltd., which is used as a carrier for the development of traditional Chinese medicine, health products and other major health industries. Recently, Hubei Guangji Health Technology Co., Ltd. has completed the industrial and commercial registration and obtained the business license issued by Wuhan Market Supervision Administration. ② Haiske: Tibet Haiske Pharmaceutical Co., Ltd., a wholly-owned subsidiary of the company, recently received an "acceptance notice" for new drug applications for innovative drugs HSK34890 tablets issued by the State Drug Administration. HSK34890 is intended for the treatment of type 2 diabetes mellitus (T2DM). ③ Dongpeng Holdings: the company and its holding subsidiary Sun Company recently obtained eight invention patents issued by the State intellectual property Office. As of the date of announcement, the company, its holding subsidiaries and Sun Company have 1515 valid patents of various types, including 326 invention patents.